Drug Shortage Report for TEVA-FULVESTRANT INJECTION
Report ID | 104353 |
Drug Identification Number | 02460130 |
Brand name | TEVA-FULVESTRANT INJECTION |
Common or Proper name | FULVESTRANT INJECTION 50MG |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | FULVESTRANT |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR |
Packaging size | 5ML |
ATC code | L02BA |
ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-01-22 |
Estimated end date | 2020-02-29 |
Actual end date | 2020-02-25 |
Shortage status | Resolved |
Updated date | 2020-02-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-02-26 | English | Compare |
v5 | 2020-02-25 | French | Compare |
v4 | 2020-02-25 | English | Compare |
v3 | 2020-02-25 | English | Compare |
v2 | 2020-01-24 | French | Compare |
v1 | 2020-01-24 | English | Compare |
Showing 1 to 6 of 6